Foreign-Trade Zone (FTZ) 27-Boston, Massachusetts, Notification of Proposed Production Activity, Wyeth Pharmaceuticals, LLC (mRNA Bulk Drug Substance), Andover, Massachusetts, 70439 [2021-26761]

Download as PDF Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Notices New York Advisory Committee. Persons interested in the work of this Committee are also directed to the Commission’s website, www.usccr.gov; persons may also contact the Regional Programs Unit office at the above email or phone number. DEPARTMENT OF COMMERCE DEPARTMENT OF COMMERCE Foreign-Trade Zones Board International Trade Administration [B–80–2021] [C–570–140] Foreign-Trade Zone (FTZ) 27—Boston, Massachusetts, Notification of Proposed Production Activity, Wyeth Pharmaceuticals, LLC (mRNA Bulk Drug Substance), Andover, Massachusetts Certain Mobile Access Equipment and Subassemblies Thereof From the People’s Republic of China: Countervailing Duty Order and Amended Final Affirmative Countervailing Duty Determination AGENCY: On September 2, 2021, the Executive Secretary of the Foreign-Trade Zones (FTZ) Board docketed an application submitted by the Port Authority of New York and New Jersey, grantee of FTZ 49, requesting subzone status subject to the existing activation limit of FTZ 49, on behalf of Getinge Group Logistics Americas LLC, in Dayton, New Jersey. The application was processed in accordance with the FTZ Act and Regulations, including notice in the Federal Register inviting public comment (86 FR 50524–50525, September 9, 2021). The FTZ staff examiner reviewed the application and determined that it meets the criteria for approval. Pursuant to the authority delegated to the FTZ Board Executive Secretary (15 CFR 400.36(f)), the application to establish Subzone 49W was approved on December 7, 2021, subject to the FTZ Act and the Board’s regulations, including Section 400.13, and further subject to FTZ 49’s 2,000acre activation limit. Wyeth Pharmaceuticals, LLC (Wyeth) submitted a notification of proposed production activity to the FTZ Board for its facility in Andover, Massachusetts within Subzone 27R. The notification conforming to the requirements of the Board’s regulations (15 CFR 400.22) was received on December 3, 2021. Pursuant to 15 CFR 400.14(b), FTZ production activity would be limited to the specific foreign-status materials/ components described in the submitted notification (summarized below) and subsequently authorized by the Board. The benefits that may stem from conducting production activity under FTZ procedures are explained in the background section of the Board’s website—accessible via www.trade.gov/ ftz. The proposed materials/components would be added to the production authority that the Board previously approved for the operation, as reflected on the Board’s website. The proposed foreign-status materials and components include Pyrophosphatase Inorganic Animal Origin Free (AOF), Rnase-Free Dnase I, Rnase Inhibitor, and Uridine-5′triphosphate (UTP) (duty rate ranges from duty-free to 6.5%). The request indicates that certain materials/ components are subject to duties under Section 301 of the Trade Act of 1974 (section 301), depending on the country of origin. The applicable Section 301 decisions require subject merchandise to be admitted to FTZs in privileged foreign status (19 CFR 146.41). Public comment is invited from interested parties. Submissions shall be addressed to the Board’s Executive Secretary and sent to: ftz@trade.gov. The closing period for their receipt is January 19, 2022. A copy of the notification will be available for public inspection in the ‘‘Online FTZ Information System’’ section of the Board’s website. For further information, contact Diane Finver at Diane.Finver@trade.gov. Dated: December 7, 2021. Elizabeth Whiteman, Acting Executive Secretary. Dated: December 6, 2021. Elizabeth Whiteman, Acting Executive Secretary. [FR Doc. 2021–26760 Filed 12–9–21; 8:45 am] [FR Doc. 2021–26761 Filed 12–9–21; 8:45 am] BILLING CODE 3510–DS–P BILLING CODE 3510–DS–P Agenda I. Welcome and Roll Call II. Announcements and Updates III. Approval of Minutes IV. Discussion: Committee’s Draft Report on Eviction Policy and Enforcement in New York V. Potential Vote To Approve the Draft Report VI. Public Comment VII. Review Next Steps VIII. Adjournment Dated: December 6, 2021. David Mussatt, Supervisory Chief, Regional Programs Unit. [FR Doc. 2021–26705 Filed 12–9–21; 8:45 am] BILLING CODE P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [S–133–2021] Approval of Subzone Status, Getinge Group Logistics Americas LLC, Dayton, New Jersey jspears on DSK121TN23PROD with NOTICES1 70439 VerDate Sep<11>2014 17:03 Dec 09, 2021 Jkt 256001 PO 00000 Frm 00010 Fmt 4703 Enforcement and Compliance, International Trade Administration, Department of Commerce. SUMMARY: Based on affirmative final determinations by the Department of Commerce (Commerce) and International Trade Commission (ITC), Commerce is issuing a countervailing duty (CVD) order on certain mobile access equipment and subassemblies thereof (mobile access equipment) from the People’s Republic of China (China). In addition, Commerce is amending its final determination with respect to mobile access equipment from China to correct several ministerial errors. DATES: Applicable December 10, 2021. FOR FURTHER INFORMATION CONTACT: Theodore Pearson or Michael Romani, AD/CVD Operations, Office I, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce, 1401 Constitution Avenue NW, Washington, DC 20230; telephone: (202) 482–2631 or (202) 482–0198, respectively. SUPPLEMENTARY INFORMATION: Background In accordance with section 705(a), 705(d), and 777(i) of the Tariff Act of 1930, as amended (the Act), on October 19, 2021, Commerce published its affirmative final determination that countervailable subsides are being provided to producers and exporters of mobile access equipment from China.1 The Coalition of American Manufacturers of Mobile Access Equipment (the petitioner) and Lingong Jinan Heavy Machinery Co., Ltd. (LGMG) submitted timely allegations on the record that Commerce made several ministerial errors in the Final Determination.2 Section 705(e) of the 1 See Certain Mobile Access Equipment and Subassemblies Thereof from the People’s Republic of China: Final Affirmative Countervailing Duty Determination, 86 FR 57809 (October 19, 2021) (Final Determination). 2 See Petitioner’s Letter, ‘‘Certain Mobile Access Equipment and Subassemblies Thereof from the People’s Republic of China: Ministerial Error Allegations,’’ dated October 20, 2021 (Petitioner Ministerial Error Allegations); see also LGMG’s Letter, ‘‘Certain Mobile Access Equipment and Continued Sfmt 4703 E:\FR\FM\10DEN1.SGM 10DEN1

Agencies

[Federal Register Volume 86, Number 235 (Friday, December 10, 2021)]
[Notices]
[Page 70439]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-26761]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-80-2021]


Foreign-Trade Zone (FTZ) 27--Boston, Massachusetts, Notification 
of Proposed Production Activity, Wyeth Pharmaceuticals, LLC (mRNA Bulk 
Drug Substance), Andover, Massachusetts

    Wyeth Pharmaceuticals, LLC (Wyeth) submitted a notification of 
proposed production activity to the FTZ Board for its facility in 
Andover, Massachusetts within Subzone 27R. The notification conforming 
to the requirements of the Board's regulations (15 CFR 400.22) was 
received on December 3, 2021.
    Pursuant to 15 CFR 400.14(b), FTZ production activity would be 
limited to the specific foreign-status materials/components described 
in the submitted notification (summarized below) and subsequently 
authorized by the Board. The benefits that may stem from conducting 
production activity under FTZ procedures are explained in the 
background section of the Board's website--accessible via 
www.trade.gov/ftz. The proposed materials/components would be added to 
the production authority that the Board previously approved for the 
operation, as reflected on the Board's website.
    The proposed foreign-status materials and components include 
Pyrophosphatase Inorganic Animal Origin Free (AOF), Rnase-Free Dnase I, 
Rnase Inhibitor, and Uridine-5'-triphosphate (UTP) (duty rate ranges 
from duty-free to 6.5%). The request indicates that certain materials/
components are subject to duties under Section 301 of the Trade Act of 
1974 (section 301), depending on the country of origin. The applicable 
Section 301 decisions require subject merchandise to be admitted to 
FTZs in privileged foreign status (19 CFR 146.41).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
[email protected]. The closing period for their receipt is January 19, 
2022.
    A copy of the notification will be available for public inspection 
in the ``Online FTZ Information System'' section of the Board's 
website.
    For further information, contact Diane Finver at 
[email protected].

    Dated: December 6, 2021.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2021-26761 Filed 12-9-21; 8:45 am]
BILLING CODE 3510-DS-P